Therefore, Salidroside treatment significantly decreased myostatin expression, but increased myogenin expression in the GN tissues of COPD rats, contributing to protection from the COPD-induced skeletal muscle atrophy in rats. The gene discussed is MSTN; the disease is chronic obstructive pulmonary disease.